Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 138

2.
3.

EWS/Fli-1 chimeric protein is a transcriptional activator.

Ohno T, Rao VN, Reddy ES.

Cancer Res. 1993 Dec 15;53(24):5859-63.

PMID:
7503813
4.

A variant Ewing's sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1.

Jeon IS, Davis JN, Braun BS, Sublett JE, Roussel MF, Denny CT, Shapiro DN.

Oncogene. 1995 Mar 16;10(6):1229-34.

PMID:
7700648
5.

Molecular heterogeneity and function of EWS-WT1 fusion transcripts in desmoplastic small round cell tumors.

Liu J, Nau MM, Yeh JC, Allegra CJ, Chu E, Wright JJ.

Clin Cancer Res. 2000 Sep;6(9):3522-9.

7.

Identification of various exon combinations of the ews/fli1 translocation: an optimized RT-PCR method for paraffin embedded tissue -- a report by the CWS-study group.

Stegmaier S, Leuschner I, Aakcha-Rudel E, Münch P, Kazanowska B, Bekassy A, Treuner J, Koscielniak E.

Klin Padiatr. 2004 Nov-Dec;216(6):315-22.

PMID:
15565546
9.

Loss of tumorigenicity of Ewing's sarcoma cells expressing antisense RNA to EWS-fusion transcripts.

Ouchida M, Ohno T, Fujimura Y, Rao VN, Reddy ES.

Oncogene. 1995 Sep 21;11(6):1049-54.

PMID:
7566963
10.

Multiple domains mediate transformation by the Ewing's sarcoma EWS/FLI-1 fusion gene.

Lessnick SL, Braun BS, Denny CT, May WA.

Oncogene. 1995 Feb 2;10(3):423-31.

PMID:
7845667
11.

A novel zinc finger gene is fused to EWS in small round cell tumor.

Mastrangelo T, Modena P, Tornielli S, Bullrich F, Testi MA, Mezzelani A, Radice P, Azzarelli A, Pilotti S, Croce CM, Pierotti MA, Sozzi G.

Oncogene. 2000 Aug 3;19(33):3799-804.

12.

A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG.

Sorensen PH, Lessnick SL, Lopez-Terrada D, Liu XF, Triche TJ, Denny CT.

Nat Genet. 1994 Feb;6(2):146-51.

PMID:
8162068
13.

The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1.

May WA, Lessnick SL, Braun BS, Klemsz M, Lewis BC, Lunsford LB, Hromas R, Denny CT.

Mol Cell Biol. 1993 Dec;13(12):7393-8.

14.

A new member of the ETS family fused to EWS in Ewing tumors.

Peter M, Couturier J, Pacquement H, Michon J, Thomas G, Magdelenat H, Delattre O.

Oncogene. 1997 Mar 13;14(10):1159-64.

15.

Biphenotypic sarcomas with myogenic and neural differentiation express the Ewing's sarcoma EWS/FLI1 fusion gene.

Sorensen PH, Shimada H, Liu XF, Lim JF, Thomas G, Triche TJ.

Cancer Res. 1995 Mar 15;55(6):1385-92.

16.

Suppression of the Ewing's sarcoma phenotype by FLI1/ERF repressor hybrids.

Athanasiou M, LeGallic L, Watson DK, Blair DG, Mavrothalassitis G.

Cancer Gene Ther. 2000 Aug;7(8):1188-95.

17.
18.

EWS/FLI-1 antagonists induce growth inhibition of Ewing tumor cells in vitro.

Kovar H, Aryee DN, Jug G, Henöckl C, Schemper M, Delattre O, Thomas G, Gadner H.

Cell Growth Differ. 1996 Apr;7(4):429-37.

19.

Analysis of the DNA-binding and transcriptional activation functions of human Fli-1 protein.

Rao VN, Ohno T, Prasad DD, Bhattacharya G, Reddy ES.

Oncogene. 1993 Aug;8(8):2167-73.

PMID:
8336942
20.

Inhibition of apoptosis by normal and aberrant Fli-1 and erg proteins involved in human solid tumors and leukemias.

Yi H, Fujimura Y, Ouchida M, Prasad DD, Rao VN, Reddy ES.

Oncogene. 1997 Mar 20;14(11):1259-68.

Supplemental Content

Support Center